Barbara Greco to Female
This is a "connection" page, showing publications Barbara Greco has written about Female.
Connection Strength
0.096
-
Greco BA, Freda BJ. What is the optimal treatment for patients with atherosclerotic renal?artery stenosis? Am J Kidney Dis. 2014 Aug; 64(2):174-7.
Score: 0.024
-
Boateng FK, Greco BA. Renal artery stenosis: prevalence of, risk factors for, and management of in-stent stenosis. Am J Kidney Dis. 2013 Jan; 61(1):147-60.
Score: 0.022
-
Germain MJ, Greco BA, Hodgins S, Chapagain B, Thadhani R, Wojciechowski D, Crisalli K, Nathanson BH, Chait Y. Assessing accuracy of estimated dry weight in dialysis patients post transplantation: the kidney knows best. J Nephrol. 2021 Dec; 34(6):2093-2097.
Score: 0.010
-
Engelman DT, Crisafi C, Germain M, Greco B, Nathanson BH, Engelman RM, Schwann TA. Stress Biomarkers Do Not Correlate With Risk Factors for Kidney Injury After Cardiac Surgery. Ann Thorac Surg. 2021 08; 112(2):532-538.
Score: 0.010
-
Engelman DT, Crisafi C, Germain M, Greco B, Nathanson BH, Engelman RM, Schwann TA. Using urinary biomarkers to reduce acute kidney injury following cardiac surgery. J Thorac Cardiovasc Surg. 2020 11; 160(5):1235-1246.e2.
Score: 0.009
-
Jalal D, McFadden M, Dwyer JP, Umanath K, Aguilar E, Yagil Y, Greco B, Sika M, Lewis JB, Greene T, Goral S. Adherence rates to ferric citrate as compared to active control in patients with end stage kidney disease on dialysis. Hemodial Int. 2017 04; 21(2):243-249.
Score: 0.007
-
Tuttle KR, Dworkin LD, Henrich W, Greco BA, Steffes M, Tobe S, Shapiro JI, Jamerson K, Lyass A, Pencina K, Massaro JM, D'Agostino RB, Cutlip DE, Murphy TP, Cooper CJ. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial. Clin J Am Soc Nephrol. 2016 07 07; 11(7):1180-1188.
Score: 0.007
-
Umanath K, Jalal DI, Greco BA, Umeukeje EM, Reisin E, Manley J, Zeig S, Negoi DG, Hiremath AN, Blumenthal SS, Sika M, Niecestro R, Koury MJ, Ma KN, Greene T, Lewis JB, Dwyer JP. Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD. J Am Soc Nephrol. 2015 Oct; 26(10):2578-87.
Score: 0.006